Tafamidis Meglumine | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tafamidis Meglumine
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Farmak Tafamidis Meglumine

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Tafamidis Meglumine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 13 USDMF, 4 EU WC, 10 NDC API, 20 Listed Suppliers, $ API Reference Price

25 API Suppliers
13 USDMF
4 EU WC
10 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 1 FDA Orange Book, 2 Europe, 1 Canada, 1 Listed Dossiers

5 FDF Dossiers
1 FDA Orange Book
2 Europe
1 Canada
1 Listed Dossiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 17 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Finished Drug Prices, 5 Annual Reports

1 US Medicaid Prescriptions
1 Finished Drug Prices
5 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 2 US Exclusivities

2 US Patents
2 US Exclusivities

$ API Ref.Price (USD/KG) : 18,074 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2FOLDRX PHARMS

filter Patent Number Reset all filters

2 All

01 17214695

02 17214696

filter API Patent Reset all filters

2 All

01 1Y

02 1Blank

filter FDF Patent Reset all filters

2 All

01 1Y

02 1Blank

filter Expiration Date Reset all filters

2 All

01 22025-12-19

Inke Tafamidis Meglumine

Product Main Page

01

FOLDRX PHARMS

TAFAMIDIS MEGLUMINE

PharmScience R&D

Not Confirmed

FOLDRX PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-19

TAFAMIDIS MEGLUMINE

US Patent Number : 7214696

Drug Substance Claim :

Drug Product Claim :

Application Number : 211996

Patent Use Code : U-2524

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-19

Portfolio PDF

Product Web Link

Digital Content

02

FOLDRX PHARMS

TAFAMIDIS MEGLUMINE

PharmScience R&D

Not Confirmed

FOLDRX PHARMS

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-19

TAFAMIDIS MEGLUMINE

US Patent Number : 7214695

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211996

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-19

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!